Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging
TRANSLATE
1 other identifier
interventional
190
1 country
2
Brief Summary
This study aims to enhance and streamline intracardiac 4D Flow magnetic resonance imaging (MRI) processing by increasing automation for the quantitative and systematic assessment of left ventricular (LV) dysfunction. The study is designed to achieve the following three objectives. The primary objective is to develop a convolutional neural network (CNN)-based deep learning model for the automatic segmentation of the LV endocardial contour throughout the cardiac cycle using intracavitary MRI data. To support model training, a dataset of LV endocardial wall segmentations will be generated from balanced steady-state free precession (bSSFP) images. A purpose-built retrospective MRI database of bSSFP images will be retrieved to accelerate training set creation. The secondary objective is to develop a numerical framework for non-invasive MRI-based pressure-volume (PV) loop reconstruction and calculation of simplified hemodynamic force descriptors (HDFs). A prospective cohort of patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) will be enrolled. Pre-procedural non-contrast 4D Flow MRI will be acquired, and non-invasive MRI-derived PV loops will be quantitatively compared with invasive catheter-based PV loop measurements. In addition, simplified HDFs will be compared with 4D Flow-derived HDFs to assess their agreement and their potential to elucidate specific features of heart failure-related LV dysfunction. The tertiary objective is to establish the foundation for a unified, standalone, and clinically deployable framework for comprehensive, automated, and clinician-friendly analysis of LV hemodynamics based on 4D Flow MRI. Internal testing, benchmarking, and structured evaluation by clinical end-users with prior 4D Flow MRI research experience will be conducted to collect feedback and guide further development and clinical translation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 13, 2025
CompletedFirst Submitted
Initial submission to the registry
February 20, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
March 6, 2026
January 1, 2026
12 months
February 20, 2026
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Accuracy of Automatic Left Ventricular Endocardial Segmentation
Accuracy of a convolutional neural network (CNN)-based model for automatic delineation of the left ventricular (LV) endocardial contour from short-axis cine balanced steady-state free precession (bSSFP) MRI images throughout the cardiac cycle. Automatically generated contours will be compared with expert manual segmentations (ground truth). Segmentation performance will be quantified using the Dice Similarity Index (DICE) and Hausdorff Distance (HD). Inter- and intra-operator variability of manual segmentation and agreement between manual and automatic contours will also be assessed using Bland-Altman analysis.
Completion of the retrospective analysis of cardiac MRI datasets (6 months)
Secondary Outcomes (4)
Agreement Between Non-Invasive MRI-Based and Invasive Pressure-Volume Loop Parameters
Up to 1 week after TAVR
Agreement Between Simplified and 4D Flow MRI-Based Hemodynamic Forces
Up to 1 week after TAVR
Correlation Between Hemodynamic Forces and LV Volumes
Up to 1 week after TAVR
Correlation Between Hemodynamic Forces and LV Global Longitudinal and Circumferential Strain
Up to 1 week after TAVR
Study Arms (1)
TRANSLATE Study Population
OTHERThe retrospective phase includes adult patients who previously underwent clinically indicated cardiac MRI for left ventricular functional assessment. The prospective phase includes patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, who undergo additional non-contrast 4D Flow MRI and standard invasive hemodynamic measurements as part of routine clinical care. Data from both phases are used for development and validation of automated MRI-based analysis methods.
Interventions
Cardiac magnetic resonance imaging, including standard cine imaging and non-contrast 4D Flow MRI acquisition. In the prospective phase, invasive and non-invasive hemodynamic signals routinely collected during the transcatheter aortic valve replacement procedure are recorded for research analysis. No additional procedures beyond standard clinical practice are required. This is a low-intervention interventional study in which all imaging acquisitions and hemodynamic measurements are performed according to standard clinical practice, with no modification of diagnostic or therapeutic pathways.
Eligibility Criteria
You may qualify if:
- Adult patients (age \> 18 years old);
- Diagnosis of severe AS defined according to ESC guidelines with indication to TAVR;
- Severe aortic stenosis both in normal/high flow status and in low flow status;
- Signed informed written consent.
You may not qualify if:
- Contraindication to cardiac MRI due to previous implant with ferromagnetic components;
- Poor MRI quality impairing image post-processing;
- Claustrophobia;
- Unwilling to sign the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
IRCCS Policlinico San Donato
San Donato Milanese, 20097, Italy
IRCCS Policlinico San Donato
San Donato Milanese, 20097, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Giandomenico Disabato, MD
IRCCS Policlinico S. Donato
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2026
First Posted
March 6, 2026
Study Start
October 13, 2025
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
March 6, 2026
Record last verified: 2026-01